Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins

9Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Population studies have shown an inverse association between high-density lipoprotein (HDL) cholesterol levels and risk of coronary heart disease (CHD). HDL has different functions, including the ability to protect biological molecules from oxidation. Our aim was to evaluate the performance of two fluorescence-based assays in assessing the antioxidative capacity of HDL. Methods: We compared the antioxidative capacity of HDL with the phospholipid 2',7'-dichlorodihydrofluorescein (DCF) assay and the dihydrorhodamine 123 (DHR) assay in controls and in subjects at increased risk of CHD, including subjects with established CHD, and subjects with elevated plasma triglycerides (TG), serum amyloid A (SAA), or myeloperoxidase (MPO) levels. Results: The antioxidative capacity of HDL, as measured by the DCF assay, was significantly lower in both CHD and high-TG patients than in controls (p < 0.001 and p = 0.004, respectively). Interestingly, the mean antioxidative capacity of HDL in high-SAA subjects was significantly higher (p < 0.03), while in high-MPO subjects was similar to controls. When the DHR assay was used we did not find differences in HDL's antioxidative capacity between CHD patients and controls but we found higher antioxidative capacity in high-SAA subjects compared to controls. Conclusions: Only the DCF assay could detect significant differences in the antioxidative capacity of HDL between controls and CHD subjects. Practical use of both assays for the assessment of antioxidative capacity of HDL is limited by the large overlap in values among groups. The antioxidative activity of HDL in patients who have elevated SAA levels needs to be reassessed.

References Powered by Scopus

High density lipoprotein as a protective factor against coronary heart disease. The Framingham study

4302Citations
N/AReaders
Get full text

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

1699Citations
N/AReaders
Get full text

High-Density Lipoprotein — The Clinical Implications of Recent Studies

1461Citations
N/AReaders
Get full text

Cited by Powered by Scopus

High-Density Lipoproteins and Serum Amyloid A (SAA)

64Citations
N/AReaders
Get full text

Role of serum amyloid A in atherosclerosis

59Citations
N/AReaders
Get full text

Update on the laboratory investigation of dyslipidemias

38Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tsunoda, F., Lamon-Fava, S., Horvath, K. V., Schaefer, E. J., & Asztalos, B. F. (2016). Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins. Lipids in Health and Disease, 15(1), 1–8. https://doi.org/10.1186/s12944-016-0336-y

Readers over time

‘16‘17‘18‘20‘21‘24‘2500.751.52.253

Readers' Seniority

Tooltip

Professor / Associate Prof. 2

33%

PhD / Post grad / Masters / Doc 2

33%

Lecturer / Post doc 1

17%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

50%

Biochemistry, Genetics and Molecular Bi... 2

25%

Computer Science 1

13%

Psychology 1

13%

Save time finding and organizing research with Mendeley

Sign up for free
0